Imatinib Completed Phase 2 Trials for Polycythemia Vera (PV) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00430066Effects of Imatinib Mesylate in Polycythemia Vera
NCT01120821Treatment of Polycythemia Vera With Gleevec